MedTrace Logo

Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer

NCT00713141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2010-08-31

No results posted yet for this study

Summary

Primary Objective

* To investigate and clearly document the presence and extent of cognitive decline, if any, in women of Asian origin following standard-dose systematic adjuvant chemotherapy for the treatment of breast cancer
* Investigation and establishment of a relationship between degree of oxidative DNA and lipid damage as indicated by plasma and urinary biochemical markers.

Secondary Objective

• To validate the use of hydrogen peroxide and serum amyloid as biomarkers of damage

Conditions

  • Early Breast Cancer

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Chiung Ing Wong, MRCP, MB ChB · National University Hospital, Singapore

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00713141 on ClinicalTrials.gov